| Page 4 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy

Author(s): 
Nakamura R, Patel BA, Kim S, Wong FL, Armenian SH, Groarke EM, Keesler DA, Hebert KM, Heim M, Eapen M, Young NS
Primary Author: 
Nakamura R
Journal Title: 
Haematologica
Original Publication Date: 
Dec 2023

Immunosuppressive treatment (IST) and hematopoietic cell transplant (HCT) are standard therapies for severe

Bone Marrow Disease(s):